Stay updated on Pyrotinib Combo in HR+/HER2- Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.

Latest updates to the Pyrotinib Combo in HR+/HER2- Clinical Trial page
- Check2 days agoChange DetectedThe footer site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check9 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedA new site revision entry (v3.7.0) was added to the record history, replacing the previous revision (v3.6.6), indicating a platform update for the study history page. This is a metadata update and does not alter the study information displayed.SummaryDifference0.1%

- Check51 days agoChange DetectedA new Revision: v3.6.6 entry was added to the study record history, and the previous Revision: v3.6.5 entry was removed.SummaryDifference0.1%

- Check72 days agoChange DetectedA new revision entry, v3.6.5, was added to the record history, and the previous entry v3.6.4 was removed from the list.SummaryDifference0.1%

- Check87 days agoChange DetectedA new revision entry labeled v3.6.4 was added to the study record history, superseding the previous v3.6.3 entry.SummaryDifference0.1%

Stay in the know with updates to Pyrotinib Combo in HR+/HER2- Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.